News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Novo Holdings A/S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/10/2021 |
SC 13D
| Novo Holdings A/S reports a 11.8% stake in IO Biotech, Inc. |
| 06/25/2021 |
SC 13D
| Novo Holdings A/S reports a 14% stake in Cyteir Therapeutics, Inc. |
| 04/14/2021 |
SC 13D
| Novo Holdings A/S reports a 14.2% stake in Reneo Pharmaceuticals, Inc. |
| 03/31/2021 |
SC 13D
| Novo Holdings A/S reports a 13.1% stake in LAVA Therapeutics N.V. |
| 03/31/2021 |
SC 13D
| Novo Holdings A/S reports a 11.4% stake in Edgewise Therapeutics, Inc. |
| 02/11/2021 |
SC 13D
| Novo Holdings A/S reports a 13% stake in Bolt Biotherapeutics, Inc. |
| 11/05/2020 |
SC 13D
| Novo Holdings A/S reports a 10.2% stake in GALECTO, INC. |
| 10/22/2020 |
SC 13D
| Novo A/S reports a 7.7% stake in Aligos Therapeutics, Inc. |
| 10/16/2020 |
SC 13D
| Novo A/S reports a 21.5% stake in Spruce Biosciences, Inc. |
| 08/13/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/29/2020 |
SC 13D
| Novo A/S reports a 11.5% stake in Inozyme Pharma, Inc. |
| 07/16/2020 |
SC 13D
| Novo A/S reports a 8.6% stake in Nkarta, Inc. |
| 07/23/2019 |
SC 13D
| Novo A/S reports a 10.6% stake in Mirum Pharmaceuticals, Inc. |
| 07/01/2019 |
SC 13D
| Novo A/S reports a 8.9% stake in Morphic Holding, Inc. |
| 05/14/2019 |
SC 13D
| Novo A/S reports a 11.3% stake in Milestone Pharmaceuticals Inc. |
| 04/02/2019 |
SC 13D
| Novo A/S reports a 13.2% stake in Verona Pharma plc |
| 01/04/2017 |
SC 13D
| Novo A/S reports a 13.6% stake in Apollo Endosurgery, Inc. |
| 11/30/2016 |
SC 13D
| Novo A/S reports a 29.2% stake in KalVista Pharmaceuticals, Inc. |
| 11/02/2016 |
SC 13D
| Novo A/S reports a 9.5% stake in Ra Pharmaceuticals, Inc. |
| 06/02/2016 |
SC 13D
| Novo A/S reports a 35.7% stake in Reata Pharmaceuticals, Inc. |
| 05/26/2016 |
SC 13D
| Merus B.V. reports a 9.1% stake in Merus N.V. |
| 03/30/2016 |
SC 13D
| Corvus Pharmaceuticals, Inc. reports a 15.5% stake in Corvus Pharmaceuticals, Inc. |
| 03/20/2007 |
SC 13D
| Novo A/S has filed a Schedule 13D for BioMimetic Therapeutics, Inc. |
|
|